Related Experiment Videos
Synthetic cannabis-induced mania
Mehmet Fatih Ustundag1, Esra Ozhan Ibis2, Atakan Yucel1
1Department of Psychiatry, Medical Faculty, Ataturk University, 25240 Erzurum, Turkey.
Case Reports in Psychiatry
|April 4, 2015
Summary
Synthetic cannabinoids (SC) are potent psychoactive drugs that are difficult to detect. This case study highlights a newly reported manic episode associated with SC use, distinct from previously documented psychosis.
Area of Science:
- Psychiatry
- Pharmacology
- Toxicology
Background:
- Synthetic cannabinoids (SC) act as agonists for cannabinoid receptors 1 and 2.
- Originally developed for medical purposes, SCs are now widely used due to accessibility, low cost, high potency, and long half-life.
- Routine drug analyses often fail to detect SCs, contributing to their prevalence.
Purpose of the Study:
- To present a case of a manic episode induced by synthetic cannabinoid use.
- To discuss the psychiatric conditions associated with the widespread use of SCs.
- To highlight a previously unreported psychiatric manifestation of SC use.
Main Methods:
- Case report presentation.
- Literature review on SC-induced psychiatric symptoms.
- Analysis of clinical presentation and psychiatric diagnosis.
Main Results:
- A patient developed a manic episode following the use of synthetic cannabinoids.
- While SC use is linked to psychosis and affective symptoms, mania has not been previously reported.
- Hospitalizations related to SC use are predominantly associated with psychotic symptoms.
Conclusions:
- Synthetic cannabinoids can induce a range of psychiatric conditions, including mania.
- This case expands the understanding of SC's neuropsychiatric effects.
- Further research is needed to fully elucidate the psychiatric risks of SC consumption.